Variables | Non-hypoxaemia group (n = 1823) | Hypoxaemia group (n = 384) | X2/Z | P-Value |
---|---|---|---|---|
Age(yrs) | 55 (44 ~ 63) | 57 (48 ~ 65) | -3.466 | 0.001 |
BMI(kg/m2) | 22.49 (20.57 ~ 24.45) | 25.35 (23.42 ~ 27.74) | -15.792 | < 0.001 |
Abdominal girth(cm) | 78 (73 ~ 83) | 87 (80 ~ 93) | -15.894 | < 0.001 |
ASA physical status | -1.621 | 0.071 | ||
I | 301 (16.5%) | 57 (14.84%) | ||
II | 1475 (80.9%) | 308 (80.20%) | ||
≥ III | 47 (2.6%) | 19 (4.96%) | ||
The modified Mallampati grade (MMP) | -25.202 | < 0.001 | ||
I | 1551 (85.1%) | 93 (24.2%) | ||
II | 254 (13.9%) | 243 (63.3%) | ||
≥ III | 18 (1%) | 48 (12.5%) | ||
Propofol dose (ug/kg/min) | 181(152 ~ 233) | 185(151 ~ 242) | -0.865 | 0.387 |
NoSAS related indexes | ||||
Male (n,%) | 925 (50.7%) | 211 (54.9%) | 2.248 | 0.134 |
Age(yrs) | 5.989 | 0.014 | ||
≤ 55 | 956 (52.40%) | 175 (45.60%) | ||
> 55 | 867 (47.60%) | 209 (54.4%) | ||
Bullnecked (Neck circumference > 40cm) | 124 (6.8%) | 216 (56.3%) | 595.107 | < 0.001 |
Snoring | 195 (10.7%) | 199 (51.80%) | 365.818 | < 0.001 |
BMI(kg/m2) | -13.866 | < 0.001 | ||
< 25 | 1469 (80.6%) | 184 (47.9%) | ||
25 ~ 30 | 327 (17.9%) | 160 (41.7%) | ||
≥ 30 | 27 (1.5%) | 40 (10.4%) | ||
NoSAS scores | 4 (2 ~ 6) | 9 (4 ~ 11) | -16.904 | < 0.001 |
NoSAS ≥ 8 | 212 (11.6%) | 224 (58.3%) | 436.442 | < 0.001 |